Canada
· Delayed Price · Currency is CAD EGF Theramed Health Statistics
Total Valuation
CSE:TMED has a market cap or net worth of CAD 1.05 million. The enterprise value is 1.14 million.
| Market Cap | 1.05M |
| Enterprise Value | 1.14M |
Important Dates
The next estimated earnings date is Friday, October 24, 2025.
| Earnings Date | Oct 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:TMED has 11.62 million shares outstanding. The number of shares has increased by 5.03% in one year.
| Current Share Class | 11.62M |
| Shares Outstanding | 11.62M |
| Shares Change (YoY) | +5.03% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -0.35 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 27.76 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.79 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.01
| Current Ratio | 0.01 |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.09 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -129.32% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 8.11% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CSE:TMED has paid 4,372 in taxes.
| Income Tax | 4,372 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.67% in the last 52 weeks. The beta is 0.56, so CSE:TMED's price volatility has been lower than the market average.
| Beta (5Y) | 0.56 |
| 52-Week Price Change | -16.67% |
| 50-Day Moving Average | 0.08 |
| 200-Day Moving Average | 0.11 |
| Relative Strength Index (RSI) | 70.03 |
| Average Volume (20 Days) | 3,518 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -3,105 |
| Operating Income | -244,657 |
| Pretax Income | -441,878 |
| Net Income | -409,964 |
| EBITDA | n/a |
| EBIT | -244,657 |
| Earnings Per Share (EPS) | -0.04 |
Balance Sheet
The company has 24,021 in cash and 1.51 million in debt, giving a net cash position of -1.49 million or -0.13 per share.
| Cash & Cash Equivalents | 24,021 |
| Total Debt | 1.51M |
| Net Cash | -1.49M |
| Net Cash Per Share | -0.13 |
| Equity (Book Value) | -3.02M |
| Book Value Per Share | -0.14 |
| Working Capital | -3.02M |
Cash Flow
| Operating Cash Flow | 37,666 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:TMED does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.03% |
| Shareholder Yield | n/a |
| Earnings Yield | -39.21% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 11, 2022. It was a reverse split with a ratio of 0.05.
| Last Split Date | Jul 11, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |